BACK TO WEBINARS Cytokine Profiles And Personalized Therapeutics In COVID-19 Patients DATE September 9, 2021 TIME & LOCATION 11am EDT/4pm BST/5pm CEST, online Recent observations by Prof. Gorochov’s team at the CIMI Research Centre suggest that there are at least two distinct types of cytokine signatures induced by SARS-CoV-2 infection. At time of hospitalization, COVID-19 patients with severe respiratory disease present low viremia and a dominant pro-inflammatory response. In contrast, less severe patients have a high viral load and elevated type-I interferon levels. Nevertheless, a strong antiviral interferon response is not always beneficial. Importantly, the risk of death was associated with the intensity of the cytokine signatures characterizing each severity group. These findings call for a personalized approach to successfully treat COVID-19 patients. Attend this webinar to: Learn about recently published observations that describe distinct cytokine profiles and COVID-19 severity and mortality Discuss the need for personalized precision medicine approach to successfully treat COVID-19 patients Explore the ultra-sensitive biomarker detection technologies that enabled these findings VIEW THE RECORDING Share this page Stay Tuned Subscribe to our newsletter SUBMIT info@quanterix.com 617 301 9400 900 middlesex tpke billerica, ma 01821 usa Investor Portal Customer Portal Contact Us Terms And Conditions Privacy Shield Statement © 2021 Quanterix All rights reserved. Privacy Policy By continuing to use this website you are acknowledging and agree with our cookie policy. AGREELearn more

SP-X Imaging and Analysis System™ Simoa-sensitive™ multiplex biomarker measurement detection REQUEST A QUOTE Want to Learn More? DOWNLOAD BROCHURE Ready to take your biomarker research to the next level? REQUEST A QUOTE Stay Tuned Subscribe to our newsletter SUBMIT info@quanterix.com 617 301 9400 900 middlesex tpke billerica, ma 01821 usa Investor Portal Customer Portal Contact Us Terms And Conditions Privacy Shield Statement © 2021 Quanterix All rights reserved. Privacy Policy By continuing to use this website you are acknowledging and agree with our cookie policy. AGREELearn more